SHA: 002693

Company Deals

Shuangcheng Pharma Licenses US Rights for Paclitaxel Injection to Meitheal

Fineline Cube Sep 26, 2022

China’s Hainan Shuangcheng Pharmaceutical Co., Ltd (SHA: 002693) has announced a licensing and supply agreement...

Company Deals

Hainan Shuangcheng to Transfer Triptorelin Assets to Chongqing Lummy for USD 4.7M

Fineline Cube Aug 2, 2022

Hainan Shuangcheng Pharmaceutical Co., Ltd (SHA: 002693) will transfer all tangible and intangible assets and...

Company Deals

QYuns Therapeutics Signs Global Licensing Deal with Caldera for Autoimmune BsAb

Company

Roche Unveils $50 Billion Five-Year US Investment Plan to Expand Manufacturing and R&D

Company Deals

China Medical System Announces Spin-off of Dermavon for HKEX IPO

Company Drug

BMS’s Cobenfy Shows Promise in Phase III ARISE Trial for Schizophrenia